jungle
发表于 2025-3-25 04:56:19
http://reply.papertrans.cn/67/6669/666888/666888_21.png
语源学
发表于 2025-3-25 08:09:18
http://reply.papertrans.cn/67/6669/666888/666888_22.png
insidious
发表于 2025-3-25 12:11:20
Book 1993o in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-st
赌博
发表于 2025-3-25 17:41:10
What Is the Value of Clinical Trials?,es are proposed or introduced that challenge these existing views. Yet challenging established views, many of which are vigorously defended with only non-randomized experience, is critical to improving treatment results for early breast cancer.
窒息
发表于 2025-3-25 20:30:00
How Much of the Axilla Should Be Dissected?,prevent complications arising from uncontrolled tumor growth in the axilla. Information on axillary Staging is vital when the axillary node status is a major determinant of the use of systemic therapy.
上腭
发表于 2025-3-26 00:21:48
http://reply.papertrans.cn/67/6669/666888/666888_26.png
歪曲道理
发表于 2025-3-26 06:44:21
Postoperative Radiotherapy and the Pattern of Distant Spread in Breast Cancer,S. 1987). However, the impact of this treatment on long-term survival remains controversial and there is a large discrepancy between the highly eflective local treatment and the somewhat modest gain in total survival (T. et al. 1986).
Vulvodynia
发表于 2025-3-26 10:47:17
http://reply.papertrans.cn/67/6669/666888/666888_28.png
PAD416
发表于 2025-3-26 14:29:45
http://reply.papertrans.cn/67/6669/666888/666888_29.png
跟随
发表于 2025-3-26 17:36:53
Treatment of the Peripheral Lymphatics: Rationale, Indications, and Techniques,but the efficacy of such radiation in patients with limited stage breast cancer continues to remain controversial despite decades of study. Results of clinical trials and sequelae of regional lymphatic radiation vary because of patient selection factors, treatment practice patterns, and design flaws in some clinical trials.